DoD Melanoma, Melanoma Academy Scholar Award
ID: 358952Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358952
Timeline
    Description

    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the FY25 Melanoma Academy Scholar Award to support early-career melanoma researchers. This grant aims to foster independent scientists who are within seven years of their initial faculty appointment by integrating them into a virtual collaborative academy that emphasizes mentorship and research development in melanoma. The program is particularly focused on three strategic research priorities: prevention and interception, studies on rare melanoma subtypes, and survivorship research, with a total funding allocation of approximately $1.76 million for two awards, each capped at $550,000 over a maximum period of three years. Interested applicants must submit a pre-application by September 10, 2025, followed by a full application due on October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942525MRPMASA_GG.pdf
    The Department of Defense (DOD) is announcing the FY25 Melanoma Academy Scholar Award under the Defense Health Program, aimed at supporting early-career melanoma researchers. The program encourages independent scientists within seven years of their initial faculty appointment to join a virtual collaborative academy that fosters mentorship and research development in melanoma. The funding opportunity has direct cost caps of $550,000 over a maximum period of three years, with approximately $1.76 million allocated for two awards. Eligibility extends to extramural and intramural organizations, and applicants must have a designated Career Guide with a strong background in melanoma research. The program focuses on three strategic research priorities: prevention and interception, studies on rare melanoma subtypes, and survivorship research. Applications must align with these focus areas and detail a comprehensive Career Development and Sustainment Plan. The application process consists of two steps: a pre-application due by September 10, 2025, followed by a full application due on October 1, 2025. The proposal review process will include compliance checks, peer review for technical merit, and assessment based on impact, career development potential, and research feasibility. This initiative aims to advance melanoma research and improve patient care, emphasizing relevance to military health and the Veteran population.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 � Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the upcoming availability of the NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32), which will support early postdoctoral fellows in cancer research. This grant program aims to enhance the pool of qualified individuals from diverse backgrounds for careers in health-related research, particularly in cancer research, by providing research training opportunities without requiring preliminary data. The application process will open on June 12, 2025, with an estimated award date of March 1, 2026, and interested applicants must identify a postdoctoral mentor and submit their applications through their respective institutions. For more information, applicants can refer to the NIH website or contact the agency directly.
    Notice of Intent to Publish Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is planning to publish a Notice of Funding Opportunity for the NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32), which will support early postdoctoral fellows in cancer research. This grant program aims to enhance the pool of qualified individuals from diverse backgrounds for careers in health-related research, particularly in cancer, by providing research training opportunities that do not require preliminary data. The program is significant for addressing cancer health disparities and enriching the scientific research experience for trainees transitioning from pre-doctoral to post-doctoral training. Interested applicants must identify a postdoctoral research mentor and submit their applications through their respective institutions, with the application deadline set for June 12, 2025, and an estimated award date of March 2, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Academic Career Excellence (ACE) Award (K32), which requires an independent clinical trial. This grant aims to support late-stage graduate students and early-stage postdoctoral scholars in cancer research, specifically targeting those transitioning to postdoctoral positions or within the first two years of their postdoctoral training. The ACE Award is crucial for enhancing the scientific research and career development of candidates, as it provides essential training support and encourages the development of a robust research plan with a designated mentor. Interested applicants should note that the first due date for submissions is anticipated to be June 12, 2025, with an estimated award date of March 2, 2026. For further details, applicants can refer to the NIH website or contact the agency directly.
    Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)," aimed at enhancing the training of a workforce to meet the nation’s biomedical and clinical research needs, particularly in cancer research. This program seeks applications that propose innovative educational activities, specifically hands-on cancer research experiences lasting 8 to 15 weeks, complemented by additional educational initiatives. With a funding ceiling of $300,000 per year for a project period of up to five years, the program encourages participation from underrepresented groups and aims to provide unique educational opportunities not covered by existing programs. Interested applicants can find more information and guidelines at the NIH website, with the application deadline set for January 25, 2026.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at fostering diversity within the cancer research workforce. This grant supports clinical scientists with doctoral degrees who are underrepresented in health-related research, providing salary support for a 3-5 year period to gain intensive research training in various cancer research fields, particularly focusing on health disparities. The program is designed to enhance the research capabilities of awardees, preparing them for independent research careers in basic biomedical, behavioral, or translational cancer research. Interested applicants should note that the application period opens on January 12, 2025, with a submission deadline of February 12, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-320.html.
    Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award in Clinical Oncology (K12), aimed at enhancing the training of clinical scientists in cancer research. This grant program is designed to support institutional research career development programs that will increase the number of clinician-scientists engaged in clinical and translational cancer research, fostering their career development through tailored mentorship and individualized plans. The program will fund a total of 15 awards, with support for a minimum of two years and a maximum of three years for each scholar, covering salary, research, and administrative costs. Interested applicants can reach out to Mark Damico, Ph.D., at damicomw@nih.gov or call 240-276-5630 for further information, with the estimated synopsis posting date on December 1, 2025, and applications expected to close by February 18, 2026.
    Forecast to Publish a Notice of Funding Opportunity for Academic Career Excellence (ACE) Award (K32 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity for the Academic Career Excellence (ACE) Award (K32 - Clinical Trial Required), aimed at supporting early-stage postdoctoral scholars in their scientific research and career development. This grant program, which does not require cost sharing or matching, will provide funding for up to three years to facilitate rigorous research and mentorship, encouraging innovative ideas and comprehensive career development plans from candidates who are nearing completion of their doctoral degrees. The NIH anticipates awarding up to 120 grants, with a funding contribution of up to $80,000 per year for salary and $30,000 per year for research development costs, with applications due by February 12, 2026. Interested applicants can reach out to Dr. Sonia B. Jakowlew at jakowles@mail.nih.gov or by phone at 240-276-5630 for further information.
    Department of Defense Research and Education Program for Historically Black Colleges and Universities and Minority-Serving Institutions (HBCU/MI)
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a federal grant opportunity through the Department of Defense Research and Education Program aimed at Historically Black Colleges and Universities and Minority-Serving Institutions (HBCUs/MIs). This initiative seeks to enhance defense-related research and educational capabilities at these institutions, with a focus on increasing the number of graduates in STEM disciplines and fostering collaborations with other educational institutions and defense organizations. The program is critical for addressing national defense research priorities and strengthening the defense workforce through educational enhancements. Eligible applicants can apply for grants ranging from $100 million, with applications due by July 31, 2029. For further inquiries, interested parties can contact William A. Creech at william.a.creech3.civ@army.mil or by phone at 919-549-4387.
    The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12), aimed at supporting newly trained clinicians committed to independent research careers in community oncology and cancer prevention. This grant opportunity encourages the development of community-based clinical trials and ancillary studies, with a strong emphasis on addressing health disparities and improving access to cancer clinical trials for underserved populations. Eligible applicants include a diverse range of organizations, particularly those serving underrepresented groups, with funding available for up to five years to support program planning and mentorship. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for February 18, 2027.